Review of the current role of targeted therapies as maintenance therapies in first and second line treatment of epithelial ovarian cancer; In the light of completed trials
| dc.contributor.author | Korkmaz, Taner | |
| dc.contributor.author | Seber, Selcuk | |
| dc.contributor.author | Basaran, Gul | |
| dc.date.accessioned | 2025-10-16T15:29:34Z | |
| dc.date.issued | 2016 | |
| dc.identifier.doi | 10.1016/j.critrevonc.2015.10.006 | |
| dc.identifier.other | WOS:000370086400018 | |
| dc.identifier.uri | https://openaccess.acibadem.edu.tr/handle/11443/8801 | |
| dc.publisher | ELSEVIER SCIENCE INC | |
| dc.source | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | |
| dc.subject | Ovarian cancer | |
| dc.subject | Maintenance treatment | |
| dc.subject | Targeted therapy | |
| dc.title | Review of the current role of targeted therapies as maintenance therapies in first and second line treatment of epithelial ovarian cancer; In the light of completed trials | |
| dc.type | Review |
